CD38 and neoplasm: Our results further demonstrated that the number of HPCs (Lin-CD34+CD38+), but not HSCs (Lin-CD34+CD38−), was more significantly decreased in the bone marrow of myeloma and negatively correlated with the quantity of CD38+CD138+ tumour cells (r =  − 0.6112).